| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-17 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-14 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |